These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6868829)

  • 1. [Results of recent intervention studies on prevention of heart disease and their significance for Switzerland].
    Epstein FH; Gutzwiller F
    Soz Praventivmed; 1983; 28(2):95-8. PubMed ID: 6868829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-based primary prevention of cardiovascular disease in Switzerland: methods and results of the National Research Program (NRP 1A).
    Gutzwiller F; Nater B; Martin J
    Prev Med; 1985 Jul; 14(4):482-91. PubMed ID: 4070186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Community-oriented prevention: the National Research Program 1A "Prevention of cardiovascular diseases in Switzerland"].
    Gutzwiller F; Junod B; Epstein FH; Jeanneret O; Schweizer W
    Soz Praventivmed; 1980 Nov; 25(5):239-43. PubMed ID: 7456748
    [No Abstract]   [Full Text] [Related]  

  • 4. [The evolution of plasma cholesterol in 2 towns with intervention programs and 2 control towns in Switzerland].
    Gutzwiller F; Nater B; Martin J
    Rev Epidemiol Sante Publique; 1985; 33(2):97-102. PubMed ID: 4035050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention and treatment of hypertension at the population level: the Minnesota Heart Health Program].
    Murray D; Luepker R; Grimm R; Blackburn H
    Kardiologiia; 1986 Jan; 26(1):78-84. PubMed ID: 3951138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The influence of family environment on the evolution of tobacco consumption in 2 trial towns and 2 control towns in Switzerland].
    Nater B; Junod B; Gutzwiller F; Wietlisbach V
    Rev Epidemiol Sante Publique; 1985; 33(2):90-6. PubMed ID: 4035049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evolution of tobacco consumption in 2 towns with intervention programs and 2 control towns in Switzerland].
    Nater B; Gutzwiller F; Abelin T; Degiampietro P; Junod B
    Rev Epidemiol Sante Publique; 1985; 33(2):80-9. PubMed ID: 4035048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of community intervention studies on cardiovascular risk factors.
    Gyarfas I
    Clin Exp Hypertens A; 1992; 14(1-2):223-37. PubMed ID: 1541038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiology and prevention of cardiovascular diseases in Switzerland].
    Gutzwiller F; Rickenbach M; Burnand B; Hausser D
    Schweiz Rundsch Med Prax; 1986 Sep; 75(40):1157-62. PubMed ID: 3775160
    [No Abstract]   [Full Text] [Related]  

  • 10. [Primary prevention of coronary heart disease: possibilities and limitations].
    Gutzwiller F
    Schweiz Rundsch Med Prax; 1990 Sep; 79(37):1050-4. PubMed ID: 2218232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Statin prescription in primary prevention: which cardiovascular risk score should be used in Switzerland?].
    Nanchen D; Chiolero A; Marques-Vidal PM; Cornuz J; Waeber G; Vollenweider P; Rodondi N
    Rev Med Suisse; 2010 Mar; 6(239):488-90, 492-3. PubMed ID: 20373694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6-year results. World Health Organisation European Collaborative Group.
    Lancet; 1986 Apr; 1(8486):869-72. PubMed ID: 2870351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [National Research Program 1A: Health Education interventions in Aarau: overview and implementation].
    Soz Praventivmed; 1980 Nov; 25(5):280-6. PubMed ID: 7456753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular risk factors: an intervention program for general practice].
    Grüninger U; Weidmann P; Abelin T; Bally C; Howald H; Mordasini R; Hochstrasser B; Lüthy R; Roschi A
    Schweiz Med Wochenschr; 1984 Dec; 114(48):1744-6. PubMed ID: 6523102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The National Research Program 1A: a community-oriented intervention study. Methodological considerations on various types of studies].
    Gutzwiller F
    Soz Praventivmed; 1980 Nov; 25(5):244-9. PubMed ID: 7006252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The National Cooperative Trial on Multifactorial Prevention of First Heart Attacks and Coronary Mortality in Free-Living, High-Risk, Middle-Aged American Men, Also Known as JUMBO: A Short Story.
    Blackburn H
    Am J Epidemiol; 2020 Jun; 189(6):491-498. PubMed ID: 31712828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial. The Multiple Risk Factor Intervention Trial Research Group.
    JAMA; 1990 Apr; 263(13):1795-801. PubMed ID: 2179590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scientific basis of the OCRA method for risk assessment of biomechanical overload of upper limb, as preferred method in ISO standards on biomechanical risk factors.
    Colombini D; Occhipinti E
    Scand J Work Environ Health; 2018 Jul; 44(4):436-438. PubMed ID: 29961081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Internal evaluation of the experience of the National Program of Research 1A on the Prevention of Cardiovascular Diseases. Swiss National Program of Research 1A. Study group].
    Soz Praventivmed; 1981 Sep; 26(4):269-76. PubMed ID: 7303937
    [No Abstract]   [Full Text] [Related]  

  • 20. Nutrition in the Multiple Risk Factor Intervention Trial (MRFIT).
    Farrand ME; Mojonnier L
    J Am Diet Assoc; 1980 Apr; 76(4):347-51. PubMed ID: 7391467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.